John Bissell, Co-CEO and Director of Origin Materials, Inc. (NASDAQ:ORGN), recently sold shares of the company worth approximately $8,260. The transaction, dated November 14, involved the sale of 6,598 shares at a weighted-average price of $1.2519 per share. This sale was conducted to cover tax withholding obligations related to the vesting and settlement of restricted stock units, as specified in the filing. Following this transaction, Bissell holds 1,617,230 shares directly.
In other recent news, Origin Materials, Inc. has announced the successful Factory Acceptance Test of its CapFormer System, paving the way for commercial production of PET caps to commence. The company reported a Q3 revenue increase to $8.2 million, up from $7.1 million year-over-year, and a solid cash position of $113 million. Origin Materials plans to deploy at least eight CapFormer Systems by the end of 2025, with initial revenue from caps expected in Q1 2025. The company is also in ongoing discussions for strategic partnerships and more business in caps and closures. Despite the positive outlook, it was noted that the company's cash balance has decreased by $45 million from the end of the previous year. According to analysts, Origin Materials is strategically positioned to capture market share in the caps and closures industry, with significant revenue growth anticipated from 2025. Positive EBITDA on a run rate basis is projected for the first half of 2026. These are recent developments in the company's operations.
InvestingPro Insights
As Origin Materials, Inc. (NASDAQ:ORGN) faces recent insider selling, it's crucial to consider the broader financial context of the company. According to InvestingPro data, ORGN's market capitalization stands at $159.6 million, with a price-to-book ratio of 0.45 as of the last twelve months ending Q3 2024. This relatively low P/B ratio could suggest that the stock is undervalued compared to its book value.
Despite the recent insider sale, InvestingPro Tips highlight that ORGN holds more cash than debt on its balance sheet, indicating a strong liquidity position. This is further supported by the fact that the company's liquid assets exceed its short-term obligations, potentially providing a financial cushion during challenging times.
However, investors should note that ORGN is quickly burning through cash and is not profitable over the last twelve months. The company's revenue growth has been impressive at 123.12% in the last twelve months, but this is coupled with a concerning operating income margin of -189.61%, suggesting significant operational challenges.
For those considering ORGN's stock, it's worth noting that InvestingPro Tips indicate the stock's RSI suggests it is in oversold territory, which could present a potential buying opportunity for some investors. However, this should be weighed against the fact that the stock has taken a big hit over the last week, with a 1-week price total return of -15.5%.
InvestingPro offers 12 additional tips for ORGN, providing a more comprehensive analysis for investors looking to delve deeper into the company's prospects.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.